Herceptin will be a big breakthrough. It's coming out now in the U.S...soon in Canada.
Herceptin is the first monoclonal antibody for breast cancer.
It targets HER2...a protein that stimulates the growth of breast cancer cells. About 30% of women with breast cancer have tumours that produce excessive amounts of HER2.